Vitesse Re-Skilling :: Programs :: Technical



Home Search Site Map Your Opinion Contact Us Français

Home > Programs > Technical > Bioprocessing > Biomanufacturing Survey

Printable Version

Bioprocessing

Vitesse logo

Biomanufacturing Training Needs Survey

Vitesse Re-Skilling^TMCanada Inc. in conjunction with the Bioprocessing Institute (BI), the Ottawa Life Sciences Council (OLSC) and Industry Canada (IC) is developing a strategy to implement industry standard training programs in biomanufacturing. The aim of this initiative seeks to provide a detailed curriculum plan that will articulate industry's unmet biopharmaceutical manufacturing training needs. As well, it will help to determine the related training services and activities of the BI, and how those training services complement existing training services nationally.

This survey consists of three parts: Part I is basic company information, whereas Parts II and III will assess the need for professional development and technical skills training. Separate individuals can fill out the different parts, as many questions regarding HR are quite distinct from those assessing technical needs.

All information will be kept completely confidential, and will be used for the purpose of this project only.

PART I: COMPANY INFORMATION

#1 Name of Company:

#2 Name of Respondent:

#3 Position:

#4 Phone Number:

#5 Fax Number:

#6 Email Address:

#7 Website Address:

#8 Year Established:

#9 Number of Employees:

#10 Ownership: (e.g. Public)

#11 Current Manufacturing Capacity:

Under 10 litres

10-50 litres

50-250 litres

250-1,000 litres

1,000-3,000 litres

#12 Activity in the GTA:

#13 Location of Manufacturing Facilities:

#14 Does your company have lab facilities?

Yes

#15 Type of Lab Facilities: (e.g. R&D, Analytical)

#16 Type of Company: [check all that apply]

Contract Manufacturing Organization (CMO)

Biopharmaceutical company that outsources its manufacturing needs

Biopharmaceutical company with in-house manufacturing capabilities

Other

#17 Please list your company's current product portfolio and it's development phase: (e.g. name of product and development phase: discovery, pre-clinical, PI, II, III or commercial):

#18 Define your company's research focus: (e.g. Mab's for cancer therapy, proteins, etc.)